Institution: University of Otago
Lead Researcher: Dr Kenny Chitcholtan
Funding Awarded: $86,667
Year/s: 2016-2017
Ascites are a build up of fluid that occurs in the abdomen during the occurrence of a variety of diseases including some ovarian cancers. The impact that ascites can have on floating ovarian cancer cells, a source of cell that can be a catalyst for secondary tumours to grow and metastasis, is not well understood. The team’s preliminary data demonstrated, in in vitro studies, that ascitic fluid reduced the effect of inhibitors including EGFR/HER-2 which are molecules present in cancer patients. This project sought to expand on these findings with the hope of understanding the effect of ascitic fluids on the responsiveness of ovarian cancer to chemotherapy. The team hoped to understand why ascites fluid helped cancer cells survive and how they could be targeted to prevent metastasis.
Knowledge Building: The team tested a variety of drugs to determine which would targets the effects of EGFR/HER-2 with published findings resulting from the work.
OCRF funding for this project has ended and the team continue to validate alternative targets and treatment options.
Read more about published findings from this project.